You know, I think meaningful patent reform, it's a federal issue, obviously, but I really think making changes so that, you know, manufacturers can't play games with the patenting system and Allow drugs to become generic and have biosimilars come to the market faster would have a big impact. Thank you. And thanks again to our all our great panelists. We really appreciate you sharing your valuable time with us today. I think really important to have all these really important perspectives on this discussion. (1:00:05–1:00:27)
CLAIM
Asserts that faster availability of generics and biosimilars would significantly impact drug costs.
This is an excerpt from a raw transcript. The assertions have not been audited or verified. Tap the video to view the source footage and understand the context.
